Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

Small Study Examines Rates Of Suicidal Ideation Concurrent With PMDD

Medscape (6/3, Lowry, Subscription Publication) reports that after examining survey responses from 256 women, researchers “found that rates of suicidal ideation concurrent with” premenstrual dysphoric disorder (PMDD) “ranged from 11% to 32% for passive and from 9% to 23% for active suicidal ideation.” Currently, “suicidal ideation (SI) is not included in the fifth edition of the” American Psychiatric Association’s “Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic criteria for PMDD,” Medscape adds. The findings were presented at the American Society of Clinical Psychopharmacology 2019 annual meeting.

Related Links:

— “Suicidal Thoughts Common in Women With PMDD, “Fran Lowry, Medscape, June 3, 2019

Physician Burnout A Widespread, Systemic Problem That Needs A Systemic Organizational Response To Solve, Expert Says

In a video segment for Healio (6/3) recorded at the American Psychiatric Association’s recent annual meeting, Rashi Aggarwal, MD, “associate professor and program director of residency training, department of psychiatry, Rutgers New Jersey Medical School, discussed” the importance of resilience, happiness, and well-being in the prevention of burnout in physicians and medical students. Dr. Aggarwal emphasized, “Physician burnout is a widespread, systemic problem that needs a systemic organizational response to solve.” While “resiliency and well-being is not yoga and broccoli alone, and it is not a solution to burnout…it is definitely something we should all know more about,” she said.

Related Links:

— “Resiliency, well-being alone are not solutions to burnout, Healio, June 3, 2019

Drug prices increasing due in part to rebates, study suggests

The San Diego Union-Tribune (5/31, Fikes) reported a new study conducted by Scripps Research found that drug rebates may be contributing to “soaring” drug prices. Researchers who “used proprietary data from Blue Cross/Blue Shield on insurance claims by more than 35 million Americans” found that the “median price of 49 top-selling brand name drugs rose 76 percent over six years,” and 48 increased in price. The study indicates the “lack of transparency on actual drug prices, along with American patent law, enable these price increases,” and while rebates “give the appearance of price reductions, they are based on ever-increasing list prices.” The findings appear “in JAMA Network Open, published by the American Medical Association.”

Related Links:

— “Price of top prescription drugs rises 76% over 6 years, Scripps Research study finds, “Bradley J. Fikes, The San Diego Union-Tribune, May 31, 2019

Foundation News

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.